Industry Research Reports

Home > Reports > Consumer Goods > Global RNA Analysis & Transcriptomic Market Research Report 2025

Global RNA Analysis & Transcriptomic Market Research Report 2025

Industry: Consumer Goods

Published Date: 2025-02-19

Pages: 95 Pages

Report ld: 4003413

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for RNA Analysis & Transcriptomic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for RNA Analysis & Transcriptomic in Clinical Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of RNA Analysis & Transcriptomic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for RNA Analysis & Transcriptomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.

The RNA Analysis & Transcriptomic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Analysis & Transcriptomic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNA Analysis & Transcriptomic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioMérieux SA
LC Sciences LLC

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference

Segment by Application

Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RNA Analysis & Transcriptomic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Microarrays

1.2.3 Sequencing

1.2.4 Polymerase Chain Reaction

1.2.5 RNA Interference

1.3 Market by Application

1.3.1 Global RNA Analysis & Transcriptomic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnostics

1.3.3 Drug Discovery

1.3.4 Toxicogenomics

1.3.5 Comparative Transcriptomics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global RNA Analysis & Transcriptomic Market Perspective (2020-2031)

2.2 Global RNA Analysis & Transcriptomic Growth Trends by Region

2.2.1 Global RNA Analysis & Transcriptomic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 RNA Analysis & Transcriptomic Historic Market Size by Region (2020-2025)

2.2.3 RNA Analysis & Transcriptomic Forecasted Market Size by Region (2026-2031)

2.3 RNA Analysis & Transcriptomic Market Dynamics

2.3.1 RNA Analysis & Transcriptomic Industry Trends

2.3.2 RNA Analysis & Transcriptomic Market Drivers

2.3.3 RNA Analysis & Transcriptomic Market Challenges

2.3.4 RNA Analysis & Transcriptomic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RNA Analysis & Transcriptomic Players by Revenue

3.1.1 Global Top RNA Analysis & Transcriptomic Players by Revenue (2020-2025)

3.1.2 Global RNA Analysis & Transcriptomic Revenue Market Share by Players (2020-2025)

3.2 Global RNA Analysis & Transcriptomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by RNA Analysis & Transcriptomic Revenue

3.4 Global RNA Analysis & Transcriptomic Market Concentration Ratio

3.4.1 Global RNA Analysis & Transcriptomic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis & Transcriptomic Revenue in 2024

3.5 Global Key Players of RNA Analysis & Transcriptomic Head office and Area Served

3.6 Global Key Players of RNA Analysis & Transcriptomic, Product and Application

3.7 Global Key Players of RNA Analysis & Transcriptomic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 RNA Analysis & Transcriptomic Breakdown Data by Type

4.1 Global RNA Analysis & Transcriptomic Historic Market Size by Type (2020-2025)

4.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2026-2031)

5 RNA Analysis & Transcriptomic Breakdown Data by Application

5.1 Global RNA Analysis & Transcriptomic Historic Market Size by Application (2020-2025)

5.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America RNA Analysis & Transcriptomic Market Size (2020-2031)

6.2 North America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America RNA Analysis & Transcriptomic Market Size by Country (2020-2025)

6.4 North America RNA Analysis & Transcriptomic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RNA Analysis & Transcriptomic Market Size (2020-2031)

7.2 Europe RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe RNA Analysis & Transcriptomic Market Size by Country (2020-2025)

7.4 Europe RNA Analysis & Transcriptomic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific RNA Analysis & Transcriptomic Market Size (2020-2031)

8.2 Asia-Pacific RNA Analysis & Transcriptomic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2020-2025)

8.4 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America RNA Analysis & Transcriptomic Market Size (2020-2031)

9.2 Latin America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America RNA Analysis & Transcriptomic Market Size by Country (2020-2025)

9.4 Latin America RNA Analysis & Transcriptomic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RNA Analysis & Transcriptomic Market Size (2020-2031)

10.2 Middle East & Africa RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2020-2025)

10.4 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific, Inc.

11.1.1 Thermo Fisher Scientific, Inc. Company Details

11.1.2 Thermo Fisher Scientific, Inc. Business Overview

11.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Introduction

11.1.4 Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.1.5 Thermo Fisher Scientific, Inc. Recent Development

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Bio-Rad Laboratories, Inc. Company Details

11.2.2 Bio-Rad Laboratories, Inc. Business Overview

11.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Introduction

11.2.4 Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.2.5 Bio-Rad Laboratories, Inc. Recent Development

11.3 Merck KGaA

11.3.1 Merck KGaA Company Details

11.3.2 Merck KGaA Business Overview

11.3.3 Merck KGaA RNA Analysis & Transcriptomic Introduction

11.3.4 Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.3.5 Merck KGaA Recent Development

11.4 Agilent Technologies, Inc.

11.4.1 Agilent Technologies, Inc. Company Details

11.4.2 Agilent Technologies, Inc. Business Overview

11.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Introduction

11.4.4 Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.4.5 Agilent Technologies, Inc. Recent Development

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Details

11.5.2 F. Hoffmann-La Roche Ltd. Business Overview

11.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Introduction

11.5.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Ltd. Recent Development

11.6 Danaher Corporation

11.6.1 Danaher Corporation Company Details

11.6.2 Danaher Corporation Business Overview

11.6.3 Danaher Corporation RNA Analysis & Transcriptomic Introduction

11.6.4 Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.6.5 Danaher Corporation Recent Development

11.7 Fluidigm Corporation

11.7.1 Fluidigm Corporation Company Details

11.7.2 Fluidigm Corporation Business Overview

11.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Introduction

11.7.4 Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.7.5 Fluidigm Corporation Recent Development

11.8 Eurofins Scientific

11.8.1 Eurofins Scientific Company Details

11.8.2 Eurofins Scientific Business Overview

11.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Introduction

11.8.4 Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.8.5 Eurofins Scientific Recent Development

11.9 Sequentia Biotech SL

11.9.1 Sequentia Biotech SL Company Details

11.9.2 Sequentia Biotech SL Business Overview

11.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Introduction

11.9.4 Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.9.5 Sequentia Biotech SL Recent Development

11.10 Acobiom

11.10.1 Acobiom Company Details

11.10.2 Acobiom Business Overview

11.10.3 Acobiom RNA Analysis & Transcriptomic Introduction

11.10.4 Acobiom Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.10.5 Acobiom Recent Development

11.11 GenXPro GmbH

11.11.1 GenXPro GmbH Company Details

11.11.2 GenXPro GmbH Business Overview

11.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Introduction

11.11.4 GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.11.5 GenXPro GmbH Recent Development

11.12 CD Genomics

11.12.1 CD Genomics Company Details

11.12.2 CD Genomics Business Overview

11.12.3 CD Genomics RNA Analysis & Transcriptomic Introduction

11.12.4 CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.12.5 CD Genomics Recent Development

11.13 Promega Corporation

11.13.1 Promega Corporation Company Details

11.13.2 Promega Corporation Business Overview

11.13.3 Promega Corporation RNA Analysis & Transcriptomic Introduction

11.13.4 Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.13.5 Promega Corporation Recent Development

11.14 Cenix BioScience GmbH

11.14.1 Cenix BioScience GmbH Company Details

11.14.2 Cenix BioScience GmbH Business Overview

11.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Introduction

11.14.4 Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.14.5 Cenix BioScience GmbH Recent Development

11.15 Takara Holdings, Inc.

11.15.1 Takara Holdings, Inc. Company Details

11.15.2 Takara Holdings, Inc. Business Overview

11.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Introduction

11.15.4 Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.15.5 Takara Holdings, Inc. Recent Development

11.16 bioMérieux SA

11.16.1 bioMérieux SA Company Details

11.16.2 bioMérieux SA Business Overview

11.16.3 bioMérieux SA RNA Analysis & Transcriptomic Introduction

11.16.4 bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.16.5 bioMérieux SA Recent Development

11.17 LC Sciences LLC

11.17.1 LC Sciences LLC Company Details

11.17.2 LC Sciences LLC Business Overview

11.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Introduction

11.17.4 LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2020-2025)

11.17.5 LC Sciences LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Microarrays

Table 3. Key Players of Sequencing

Table 4. Key Players of Polymerase Chain Reaction

Table 5. Key Players of RNA Interference

Table 6. Global RNA Analysis & Transcriptomic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global RNA Analysis & Transcriptomic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global RNA Analysis & Transcriptomic Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global RNA Analysis & Transcriptomic Market Share by Region (2020-2025)

Table 10. Global RNA Analysis & Transcriptomic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global RNA Analysis & Transcriptomic Market Share by Region (2026-2031)

Table 12. RNA Analysis & Transcriptomic Market Trends

Table 13. RNA Analysis & Transcriptomic Market Drivers

Table 14. RNA Analysis & Transcriptomic Market Challenges

Table 15. RNA Analysis & Transcriptomic Market Restraints

Table 16. Global RNA Analysis & Transcriptomic Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global RNA Analysis & Transcriptomic Market Share by Players (2020-2025)

Table 18. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2024)

Table 19. Ranking of Global Top RNA Analysis & Transcriptomic Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by RNA Analysis & Transcriptomic Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of RNA Analysis & Transcriptomic, Headquarters and Area Served

Table 22. Global Key Players of RNA Analysis & Transcriptomic, Product and Application

Table 23. Global Key Players of RNA Analysis & Transcriptomic, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global RNA Analysis & Transcriptomic Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2020-2025)

Table 27. Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2026-2031)

Table 29. Global RNA Analysis & Transcriptomic Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2020-2025)

Table 31. Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2026-2031)

Table 33. North America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific RNA Analysis & Transcriptomic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)

Table 48. Thermo Fisher Scientific, Inc. Company Details

Table 49. Thermo Fisher Scientific, Inc. Business Overview

Table 50. Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Product

Table 51. Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 52. Thermo Fisher Scientific, Inc. Recent Development

Table 53. Bio-Rad Laboratories, Inc. Company Details

Table 54. Bio-Rad Laboratories, Inc. Business Overview

Table 55. Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Product

Table 56. Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 57. Bio-Rad Laboratories, Inc. Recent Development

Table 58. Merck KGaA Company Details

Table 59. Merck KGaA Business Overview

Table 60. Merck KGaA RNA Analysis & Transcriptomic Product

Table 61. Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 62. Merck KGaA Recent Development

Table 63. Agilent Technologies, Inc. Company Details

Table 64. Agilent Technologies, Inc. Business Overview

Table 65. Agilent Technologies, Inc. RNA Analysis & Transcriptomic Product

Table 66. Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 67. Agilent Technologies, Inc. Recent Development

Table 68. F. Hoffmann-La Roche Ltd. Company Details

Table 69. F. Hoffmann-La Roche Ltd. Business Overview

Table 70. F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Product

Table 71. F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 72. F. Hoffmann-La Roche Ltd. Recent Development

Table 73. Danaher Corporation Company Details

Table 74. Danaher Corporation Business Overview

Table 75. Danaher Corporation RNA Analysis & Transcriptomic Product

Table 76. Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 77. Danaher Corporation Recent Development

Table 78. Fluidigm Corporation Company Details

Table 79. Fluidigm Corporation Business Overview

Table 80. Fluidigm Corporation RNA Analysis & Transcriptomic Product

Table 81. Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 82. Fluidigm Corporation Recent Development

Table 83. Eurofins Scientific Company Details

Table 84. Eurofins Scientific Business Overview

Table 85. Eurofins Scientific RNA Analysis & Transcriptomic Product

Table 86. Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 87. Eurofins Scientific Recent Development

Table 88. Sequentia Biotech SL Company Details

Table 89. Sequentia Biotech SL Business Overview

Table 90. Sequentia Biotech SL RNA Analysis & Transcriptomic Product

Table 91. Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 92. Sequentia Biotech SL Recent Development

Table 93. Acobiom Company Details

Table 94. Acobiom Business Overview

Table 95. Acobiom RNA Analysis & Transcriptomic Product

Table 96. Acobiom Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 97. Acobiom Recent Development

Table 98. GenXPro GmbH Company Details

Table 99. GenXPro GmbH Business Overview

Table 100. GenXPro GmbH RNA Analysis & Transcriptomic Product

Table 101. GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 102. GenXPro GmbH Recent Development

Table 103. CD Genomics Company Details

Table 104. CD Genomics Business Overview

Table 105. CD Genomics RNA Analysis & Transcriptomic Product

Table 106. CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 107. CD Genomics Recent Development

Table 108. Promega Corporation Company Details

Table 109. Promega Corporation Business Overview

Table 110. Promega Corporation RNA Analysis & Transcriptomic Product

Table 111. Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 112. Promega Corporation Recent Development

Table 113. Cenix BioScience GmbH Company Details

Table 114. Cenix BioScience GmbH Business Overview

Table 115. Cenix BioScience GmbH RNA Analysis & Transcriptomic Product

Table 116. Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 117. Cenix BioScience GmbH Recent Development

Table 118. Takara Holdings, Inc. Company Details

Table 119. Takara Holdings, Inc. Business Overview

Table 120. Takara Holdings, Inc. RNA Analysis & Transcriptomic Product

Table 121. Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 122. Takara Holdings, Inc. Recent Development

Table 123. bioMérieux SA Company Details

Table 124. bioMérieux SA Business Overview

Table 125. bioMérieux SA RNA Analysis & Transcriptomic Product

Table 126. bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 127. bioMérieux SA Recent Development

Table 128. LC Sciences LLC Company Details

Table 129. LC Sciences LLC Business Overview

Table 130. LC Sciences LLC RNA Analysis & Transcriptomic Product

Table 131. LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)

Table 132. LC Sciences LLC Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. RNA Analysis & Transcriptomic Picture

Figure 2. Global RNA Analysis & Transcriptomic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global RNA Analysis & Transcriptomic Market Share by Type: 2024 VS 2031

Figure 4. Microarrays Features

Figure 5. Sequencing Features

Figure 6. Polymerase Chain Reaction Features

Figure 7. RNA Interference Features

Figure 8. Global RNA Analysis & Transcriptomic Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global RNA Analysis & Transcriptomic Market Share by Application: 2024 VS 2031

Figure 10. Clinical Diagnostics Case Studies

Figure 11. Drug Discovery Case Studies

Figure 12. Toxicogenomics Case Studies

Figure 13. Comparative Transcriptomics Case Studies

Figure 14. RNA Analysis & Transcriptomic Report Years Considered

Figure 15. Global RNA Analysis & Transcriptomic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global RNA Analysis & Transcriptomic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global RNA Analysis & Transcriptomic Market Share by Region: 2024 VS 2031

Figure 18. Global RNA Analysis & Transcriptomic Market Share by Players in 2024

Figure 19. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by RNA Analysis & Transcriptomic Revenue in 2024

Figure 21. North America RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America RNA Analysis & Transcriptomic Market Share by Country (2020-2031)

Figure 23. United States RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe RNA Analysis & Transcriptomic Market Share by Country (2020-2031)

Figure 27. Germany RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific RNA Analysis & Transcriptomic Market Share by Region (2020-2031)

Figure 35. China RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America RNA Analysis & Transcriptomic Market Share by Country (2020-2031)

Figure 43. Mexico RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa RNA Analysis & Transcriptomic Market Share by Country (2020-2031)

Figure 47. Turkey RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Thermo Fisher Scientific, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 51. Bio-Rad Laboratories, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 52. Merck KGaA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 54. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 55. Danaher Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 56. Fluidigm Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 57. Eurofins Scientific Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 58. Sequentia Biotech SL Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 59. Acobiom Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 60. GenXPro GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 61. CD Genomics Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 62. Promega Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 63. Cenix BioScience GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 64. Takara Holdings, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 65. bioMérieux SA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 66. LC Sciences LLC Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global RNA Analysis & Transcriptomic market? zhanKai

The top companies in the global RNA Analysis & Transcriptomic market are Thermo Fisher Scientific, Inc.、Bio-Rad Laboratories, Inc.、Merck KGaA.

Related Reports

RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 121
USD 3950.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2026
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 128
USD 2900.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Outlook, In‑Depth Analysis & Forecast to 2031
The global RNA Analysis & Transcriptomic market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 155
USD 4900.00
(Single User License)
Global RNA Analysis & Transcriptomic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global RNA Analysis & Transcriptomic market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 101
USD 4250.00
(Single User License)
RNA Analysis & Transcriptomic- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 126
USD 3950.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Insights, Forecast to 2030
Market Analysis and Insights: Global RNA Analysis & Transcriptomic Market
Published Date: 2024-04-07
Pages: 112
USD 4900.00
(Single User License)
RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2024
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 92
USD 2900.00
(Single User License)

RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 121
USD 3950.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2026
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 128
USD 2900.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Outlook, In‑Depth Analysis & Forecast to 2031
The global RNA Analysis & Transcriptomic market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 155
USD 4900.00 (Single User License)
Global RNA Analysis & Transcriptomic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global RNA Analysis & Transcriptomic market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 101
USD 4250.00 (Single User License)
RNA Analysis & Transcriptomic- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 126
USD 3950.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Insights, Forecast to 2030
Market Analysis and Insights: Global RNA Analysis & Transcriptomic Market
Published: 2024-04-07
Pages: 112
USD 4900.00 (Single User License)
RNA Analysis & Transcriptomic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for RNA Analysis & Transcriptomic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 126
USD 3950.00 (Single User License)
Global RNA Analysis & Transcriptomic Market Research Report 2024
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 92
USD 2900.00 (Single User License)